These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2126464)

  • 21. The anticoagulant activation of antithrombin by heparin.
    Jin L; Abrahams JP; Skinner R; Petitou M; Pike RN; Carrell RW
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14683-8. PubMed ID: 9405673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Lys335 in the metastability and function of inhibitory serpins.
    Im H; Yu MH
    Protein Sci; 2000 May; 9(5):934-41. PubMed ID: 10850803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?
    Petitou M; van Boeckel CA
    Angew Chem Int Ed Engl; 2004 Jun; 43(24):3118-33. PubMed ID: 15199558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
    Stone SR; Le Bonniec BF
    J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cells.
    Ersdal-Badju E; Lu A; Peng X; Picard V; Zendehrouh P; Turk B; Björk I; Olson ST; Bock SC
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):323-30. PubMed ID: 7646463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and characterization of recombinant human antithrombin III in Pichia pastoris.
    Mochizuki S; Hamato N; Hirose M; Miyano K; Ohtani W; Kameyama S; Kuwae S; Tokuyama T; Ohi H
    Protein Expr Purif; 2001 Oct; 23(1):55-65. PubMed ID: 11570846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of glycosylation on heparin binding and antithrombin activation by heparin.
    Pol-Fachin L; Franco Becker C; Almeida Guimarães J; Verli H
    Proteins; 2011 Sep; 79(9):2735-45. PubMed ID: 21769943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of heparin and glucose on structural conformation of human alpha1 antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor.
    Finotti P; de Laureto PP
    Arch Biochem Biophys; 1997 Nov; 347(1):19-29. PubMed ID: 9344460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.
    Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA
    Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure of cleaved bovine antithrombin III at 3.2 A resolution.
    Mourey L; Samama JP; Delarue M; Petitou M; Choay J; Moras D
    J Mol Biol; 1993 Jul; 232(1):223-41. PubMed ID: 8331659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin.
    Huntington JA; Gettins PG
    Biochemistry; 1998 Mar; 37(10):3272-7. PubMed ID: 9521646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombin III Budapest: a single amino acid substitution (429Pro to Leu) in a region highly conserved in the serpin family.
    Olds RJ; Lane DA; Caso R; Panico M; Morris HR; Sas G; Dawes J; Thein SL
    Blood; 1992 Mar; 79(5):1206-12. PubMed ID: 1536946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel approach for preparation of heparins specific to factor Xa using affinity chromatography coupled with synthetic antithrombin III-related peptides.
    Onoue S; Harada S; Nemoto Y; Yajima T; Kashimoto K
    Peptides; 2003 Jun; 24(6):821-6. PubMed ID: 12948833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial glycosylation of antithrombin III asparagine-135 is caused by the serine in the third position of its N-glycosylation consensus sequence and is responsible for production of the beta-antithrombin III isoform with enhanced heparin affinity.
    Picard V; Ersdal-Badju E; Bock SC
    Biochemistry; 1995 Jul; 34(26):8433-40. PubMed ID: 7599134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-function relations of antithrombin III-heparin interactions as assessed by biophysical and biological assays and molecular modeling of peptide-pentasaccharide-docked complexes.
    Tyler-Cross R; Sobel M; McAdory LE; Harris RB
    Arch Biochem Biophys; 1996 Oct; 334(2):206-13. PubMed ID: 8900394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Energetics of hydrogen bond switch, residue burial and cavity analysis reveals molecular basis of improved heparin binding to antithrombin.
    Singh P; Singh K; Jairajpuri MA
    J Biomol Struct Dyn; 2011 Oct; 29(2):339-50. PubMed ID: 21875153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystallization and preliminary X-ray analysis of human antithrombin III.
    Schreuder H; de Boer B; Pronk S; Hol W; Dijkema R; Mulders J; Theunissen H
    J Mol Biol; 1993 Jan; 229(1):249-50. PubMed ID: 8421307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 2.1 A resolution structure of an uncleaved alpha(1)-antitrypsin shows variability of the reactive center and other loops.
    Kim S; Woo J; Seo EJ; Yu M; Ryu S
    J Mol Biol; 2001 Feb; 306(1):109-19. PubMed ID: 11178897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.
    Desai UR; Petitou M; Björk I; Olson ST
    Biochemistry; 1998 Sep; 37(37):13033-41. PubMed ID: 9737884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
    Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
    Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.